Cyclacel Pharmaceuticals, Inc

CYCC XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

15M

Short interest (Aug 29)

4.3%

Net Short (Sep 11 ): -1.9%

Borrow Fee

300.24%

↓ 33.3%

Available Shares

40K

↑ 24.8%

Price Chart

Company Overview

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001130166

Asset Type: CS

Market Data

Market Cap: $15,157,921

Employees: 12

Status: Active

Short Interest

Current Borrow Fee 300.24%

Range: 291.94% - 300.24%

Available Shares 40K

Range: 30K - 60K

Recent Changes

Fee Change: ↓ 0.6%

Available Change: ↑ 33.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime